scemblix comprimé
novartis pharmaceuticals canada inc - asciminib (chlorhydrate d'asciminib) - comprimé - 20mg - asciminib (chlorhydrate d'asciminib) 20mg
scemblix comprimé
novartis pharmaceuticals canada inc - asciminib (chlorhydrate d'asciminib) - comprimé - 40mg - asciminib (chlorhydrate d'asciminib) 40mg
scemblix
novartis europharm limited - asciminib hydrochloride - leucémie, myélogène, chronique, bcr-abl positif - agents antinéoplasiques - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
scemblix 20 mg comprimés pelliculés
novartis pharma schweiz ag - asciminibum - comprimés pelliculés - asciminibum 20 mg ut asciminibi hydrochloridum 21.62 mg, lactosum monohydricum 43.11 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), e 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, e 172 (flavum), e 172 (rubrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.47 mg. - behandlung von erwachsenen patienten mit philadelphia-chromosom-positiver chronisch-myeloischer leukämie (ph+ cml) in der chronischen phase (cp) - synthetika
scemblix 40 mg comprimés pelliculés
novartis pharma schweiz ag - asciminibum - comprimés pelliculés - asciminibum 40 mg ut asciminibi hydrochloridum 43.24 mg, lactosum monohydricum 86.22 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), e 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, e 172 (rubrum), e 172 (nigrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.93 mg. - behandlung von erwachsenen patienten mit philadelphia-chromosom-positiver chronisch-myeloischer leukämie (ph+ cml) in der chronischen phase (cp) - synthetika
axitinib eg 1 mg compr. pellic.
eg sa-nv - axitinib 1 mg - comprimé pelliculé - axitinib
axitinib eg 3 mg compr. pellic.
eg sa-nv - axitinib 3 mg - comprimé pelliculé - axitinib
axitinib eg 5 mg compr. pellic.
eg sa-nv - axitinib 5 mg - comprimé pelliculé - axitinib
axitinib eg 7 mg compr. pellic.
eg sa-nv - axitinib 7 mg - comprimé pelliculé - axitinib
axitinib spirig hc 1 mg comprimés pelliculés
spirig healthcare ag - axitinibum - comprimés pelliculés - axitinibum 1 mg, lactosum monohydricum 32 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.087 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 1.12 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinome à cellules rénales - synthetika